A double-blind, randomized, placebo controlled, partial 4-way crossover interaction study to examine the effects of a single dose of haloperidol or placebo on THC-induced CNS effects in healthy male volunteers
- Conditions
- psychosendenkstoornis)hallucinatiespsychosis (wanen
- Registration Number
- NL-OMON32373
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
See protocol paragraph 3.2
Exclusion Criteria
See protocol paragraph 3.3
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To examine the effects of haloperidol on the CNS-effects of THC compared to<br /><br>placebo. </p><br>
- Secondary Outcome Measures
Name Time Method <p>To examine the CNS-effects of haloperidol<br /><br>To examine the CNS-effects of THC </p><br>